The global neuroendocrine carcinoma treatment market is poised for substantial growth, with revenue expected to reach USD ...

A Fort Wright mom of four battling an extremely rare cancer is now helping in the fight for a cure. Five years ago, Kristy ...

A GRASSINGTON woman conquered her fear of heights and took to the skies in a glider to raise money for a cancer charity close ...

BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on ...

Real-world data showed mean BMI decrease of 12.8% in adult patients with acquired hypothalamic obesity (N=8) at three months ...

Citi analyst David Lebowitz has maintained their bullish stance on CRNX stock, giving a Buy rating yesterday. David Lebowitz’s rating is ...

Australia is on the brink of a healthcare revolution driven by DNA science that will save lives and prevent disease – but top ...

Robert W. Baird analyst Brian Skorney maintained a Buy rating on Crinetics Pharmaceuticals (CRNX – Research Report) on November 12 and ...

The global keloid treatment market, valued at USD 3.8 billion in 2023, is projected to grow significantly, reaching an ...

Cash and Cash Equivalents: As of September 30, 2024, Senti Bio held cash and cash equivalents of $10.5 million. Subsequent to quarter-end, the Company received $2.5 million, the second tranche of an ...

In 2015, researchers discovered that some species, like Conus geographus, make venoms that contain con-insulin, a toxin that ...